The approach that drives every programme we build
Every programme we build maps directly to the UN Sustainable Development Goals — specifically SDG 3 (Good Health and Well-being) and SDG 10 (Reduced Inequalities). This isn’t a branding exercise. It means every partnership we take on contributes to a measurable, internationally recognised framework for health equity in Africa. For our partners, that alignment has real value — both editorially and in ESG reporting.
We don’t build programmes to fill a commercial calendar. We identify areas where the burden of disease is high, the evidence base is strong, and the gap between what practitioners know and what they need to know is measurable. That gap is where our programmes live. Partners who come to us are aligning their investment with a genuine clinical priority — not a market opportunity.
We run a small number of flagship programmes each year. That is a deliberate choice. It means every programme receives the full weight of our editorial rigour, our community relationships, and our production capability. We are not a volume business. We are a quality business — and our community trusts us precisely because they know we don’t take on work we can’t do well.
How MedED programmes differ from typical medcomms offerings in the market
Not adapted. Not translated. Built from the ground up for the clinical realities, resource constraints, and disease burden of sub-Saharan Africa. Our speakers practise here. Our audience works here.
Partners fund the platform that makes a programme possible. They do not write it, edit it, or steer it. That independence is why our community trusts the content — and why your brand benefits from being associated with it.
Our [9,800]+ verified HCPs are not a mailing list. They are practitioners who subscribed because the content is useful. Engagement rates reflect a community that reads, watches, and acts on what we publish.
We track what matters: reach into verified specialities, content engagement depth, and, where possible, behaviour change indicators. Every flagship programme is supported by impact reporting. Case studies and outcome data are available on request.
Outcomes that matter to you and our practitioners
From the organisations who have partnered with us
A rigorous process that protects both the community and the partnership
We identify the clinical area, the evidence gap, and the practitioner audience before we ever approach a partner. Programmes are need-led, not commercially led.
We work with you to find the programme that best fits your objectives, therapeutic area, and target audience. Alignment goes both ways — the right match is better for you, your audience, and the community we serve.
We work collaboratively on scope, format, and KOL selection. Partners are consulted and kept informed. Content development remains under MedED editorial control throughout.
The programme launches across the MedED platform and network. We track reach, engagement, and impact throughout, and provide a full post-programme impact report to every partner.
Relationships forged in shared commitments. Content that remains live, searchable, and discoverable for it's clinically relevant term. Most flagship programmes continue generating meaningful engagement 12–24 months after launch. Your investment keeps working.